Lecture
Parkinson's Disease Drug Development
Description
This lecture by the instructor covers the preclinical strategy for developing drugs in Parkinson's Disease, including establishing a research and development organization, disease representation, genetic evidence, and potential therapeutic strategies. It also discusses target identification, drug modality selection, molecular mechanisms like a-syn aggregation, building assay pipelines, and external innovation partnerships.
Official source
About this result
This page is automatically generated and may contain information that is not correct, complete, up-to-date, or relevant to your search query. The same applies to every other page on this website. Please make sure to verify the information with EPFL's official sources.